Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The technology used in COVID-19 vaccines may also be used to prevent other viral infections and to treat cancer and multiple sclerosis.
Screening patients for autoantibodies against interferons could help predict which patients are more likely to become very sick.
An overactive immune system is the main reason that many people with both cancer and autoimmune diseases aren’t included in clinical trials.
The technology that uncovered antibody has the potential to identify other autoimmune diseases.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.